In continuation to our communication in accordance SERI Circular No. SEBI/HO/MIRSD/DOP/CIR/P/2020/28
dated February 25, 2020 in connection with the Pledge and Re-Pledge of securities
with Clearing Member / Clearing Corporation.
11th Floor, " Grandeur ",Opp. Gundeecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W),Mumbai,Maharashtra-400053
Marksans Pharma Ltd. was incorporated in the year 1992. Its today's share price is 82.45. Its current market capitalisation stands at Rs 3374.79 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4334.15 Cr and Total Income of Rs.4335.88 Cr. The company's management includes Harshavardhan Panigrahi, Abhinna Sundar Mohanty, Digant Mahesh Parikh, Seetharama Raju Buddharaju, Varddhman Vikramaditya Jain, Sandra Saldanha, Mark Saldanha, Mark Saldanha. It is listed on the BSE with a BSE Code of 524404 , NSE with an NSE Symbol of MARKSANS and ISIN of INE750C01026. It's Registered office is at 11th Floor, " Grandeur ",Opp. Gundeecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W)Mumbai-400053, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Bhuta Shah & Co LLP, NK Mittal & Associates, VS Lalpuria & Co
© NIRMAL BANG. All rights reserved
Designed , Developed & Content Powered by ●●●
Accord Fintech Pvt. Ltd.
Please fill in the details below
(Note - You will receive a call from our sales executive)
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document,
Do's & Don't's) in Vernacular Language :